APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis B Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hepatitis B Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026187 pages

Choose your research edition.

Industry ResearchHepatitis B Drug Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis B Drug Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Hepatitis B Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis B Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis B Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Hepatitis B Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Hepatitis B Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hepatitis B Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepatitis B Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hepatitis B Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepatitis B Drug include Bristol-Myers Squibb, Gilead Sciences, Merck & Co. Inc., Mitsubishi Tanabe Pharma, AbbVie, GlaxoSmithKline, Roche, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Hepatitis B Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hepatitis B Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hepatitis B Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hepatitis B Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Hepatitis B Drug Segment by Company

Bristol-Myers Squibb

Gilead Sciences

Merck & Co. Inc.

Mitsubishi Tanabe Pharma

AbbVie

GlaxoSmithKline

Roche

Novartis

Johnson & Johnson

Hepatitis B Drug Segment by Type

Tenofovir

Telbivudine

Lamivudine

Entecavir

Adefovir

Others

Hepatitis B Drug Segment by Application

Hospital Pharmacies

Retail Pharmacies & Drug Stores

Others

Hepatitis B Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis B Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hepatitis B Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hepatitis B Drug industry.

Chapter 3: Detailed analysis of Hepatitis B Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis B Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hepatitis B Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tenofovir Table 3. Key Players of Telbivudine Table 4. Key Players of Lamivudine Table 3. Key Players of Entecavir Table 4. Key Players of Adefovir Table 5. Key Players of Others Table 6. Global Hepatitis B Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Hospital Pharmacies Table 8. Key Players of Retail Pharmacies & Drug Stores Table 9. Key Players of Others Table 10. Global Hepatitis B Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Hepatitis B Drug Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Hepatitis B Drug Market Share by Region (2021-2026) Table 13. Global Hepatitis B Drug Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Hepatitis B Drug Market Share by Region (2027-2032) Table 15. Hepatitis B Drug Industry Trends Table 16. Hepatitis B Drug Industry Drivers Table 17. Hepatitis B Drug Industry Opportunities and Challenges Table 18. Hepatitis B Drug Industry Restraints Table 19. Global Hepatitis B Drug Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Hepatitis B Drug Revenue Market Share by Company (2021-2026) Table 21. Global Hepatitis B Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Hepatitis B Drug Key Company Head Office and Area Served Table 23. Global Hepatitis B Drug Company, Product Type & Application Table 24. Global Hepatitis B Drug Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Hepatitis B Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Hepatitis B Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Hepatitis B Drug Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Hepatitis B Drug Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Hepatitis B Drug Revenue Market Share by Type (2021-2026) Table 31. Global Hepatitis B Drug Revenue Market Share by Type (2027-2032) Table 32. Global Hepatitis B Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hepatitis B Drug Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Hepatitis B Drug Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Hepatitis B Drug Revenue Market Share by Application (2021-2026) Table 36. Global Hepatitis B Drug Revenue Market Share by Application (2027-2032) Table 37. Bristol-Myers Squibb Company Information Table 38. Bristol-Myers Squibb Business Overview Table 39. Bristol-Myers Squibb Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Bristol-Myers Squibb Hepatitis B Drug Product Portfolio Table 41. Bristol-Myers Squibb Recent Development Table 42. Gilead Sciences Company Information Table 43. Gilead Sciences Business Overview Table 44. Gilead Sciences Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Gilead Sciences Hepatitis B Drug Product Portfolio Table 46. Gilead Sciences Recent Development Table 47. Merck & Co. Inc. Company Information Table 48. Merck & Co. Inc. Business Overview Table 49. Merck & Co. Inc. Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Merck & Co. Inc. Hepatitis B Drug Product Portfolio Table 51. Merck & Co. Inc. Recent Development Table 52. Mitsubishi Tanabe Pharma Company Information Table 53. Mitsubishi Tanabe Pharma Business Overview Table 54. Mitsubishi Tanabe Pharma Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Mitsubishi Tanabe Pharma Hepatitis B Drug Product Portfolio Table 56. Mitsubishi Tanabe Pharma Recent Development Table 57. AbbVie Company Information Table 58. AbbVie Business Overview Table 59. AbbVie Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. AbbVie Hepatitis B Drug Product Portfolio Table 61. AbbVie Recent Development Table 62. GlaxoSmithKline Company Information Table 63. GlaxoSmithKline Business Overview Table 64. GlaxoSmithKline Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. GlaxoSmithKline Hepatitis B Drug Product Portfolio Table 66. GlaxoSmithKline Recent Development Table 67. Roche Company Information Table 68. Roche Business Overview Table 69. Roche Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Roche Hepatitis B Drug Product Portfolio Table 71. Roche Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Novartis Hepatitis B Drug Product Portfolio Table 76. Novartis Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Johnson & Johnson Hepatitis B Drug Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. North America Hepatitis B Drug Market Size by Type (2021-2026) & (US$ Million) Table 83. North America Hepatitis B Drug Market Size by Type (2027-2032) & (US$ Million) Table 84. North America Hepatitis B Drug Market Size by Application (2021-2026) & (US$ Million) Table 85. North America Hepatitis B Drug Market Size by Application (2027-2032) & (US$ Million) Table 86. North America Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Hepatitis B Drug Market Size by Country (2021-2026) Table 88. North America Hepatitis B Drug Market Size by Country (2027-2032) Table 89. Europe Hepatitis B Drug Market Size by Type (2021-2026) & (US$ Million) Table 90. Europe Hepatitis B Drug Market Size by Type (2027-2032) & (US$ Million) Table 91. Europe Hepatitis B Drug Market Size by Application (2021-2026) & (US$ Million) Table 92. Europe Hepatitis B Drug Market Size by Application (2027-2032) & (US$ Million) Table 93. Europe Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Hepatitis B Drug Market Size by Country (2021-2026) Table 95. Europe Hepatitis B Drug Market Size by Country (2027-2032) Table 96. China Hepatitis B Drug Market Size by Type (2021-2026) & (US$ Million) Table 97. China Hepatitis B Drug Market Size by Type (2027-2032) & (US$ Million) Table 98. China Hepatitis B Drug Market Size by Application (2021-2026) & (US$ Million) Table 99. China Hepatitis B Drug Market Size by Application (2027-2032) & (US$ Million) Table 100. Asia Hepatitis B Drug Market Size by Type (2021-2026) & (US$ Million) Table 101. Asia Hepatitis B Drug Market Size by Type (2027-2032) & (US$ Million) Table 102. Asia Hepatitis B Drug Market Size by Application (2021-2026) & (US$ Million) Table 103. Asia Hepatitis B Drug Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Hepatitis B Drug Market Size by Country (2021-2026) Table 106. Asia Hepatitis B Drug Market Size by Country (2027-2032) Table 107. South America, Middle East & Africa Hepatitis B Drug Market Size by Type (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Hepatitis B Drug Market Size by Type (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Hepatitis B Drug Market Size by Application (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Hepatitis B Drug Market Size by Application (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. South America, Middle East & Africa Hepatitis B Drug Market Size by Country (2021-2026) Table 113. South America, Middle East & Africa Hepatitis B Drug Market Size by Country (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Hepatitis B Drug Product Image Figure 2. Global Hepatitis B Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Hepatitis B Drug Market Share by Type: 2025 VS 2032 Figure 4. Tenofovir Image Figure 5. Telbivudine Image Figure 6. Lamivudine Image Figure 7. Entecavir Image Figure 8. Adefovir Image Figure 9. Others Image Figure 10. Global Hepatitis B Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Hepatitis B Drug Market Share by Application: 2025 VS 2032 Figure 12. Hospital Pharmacies Image Figure 13. Retail Pharmacies & Drug Stores Image Figure 14. Others Image Figure 15. Global Hepatitis B Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 17. Global Hepatitis B Drug Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Hepatitis B Drug Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Hepatitis B Drug Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Hepatitis B Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hepatitis B Drug Revenue Market Share by Type (2021-2032) Figure 24. Global Hepatitis B Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Hepatitis B Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 27. North America Hepatitis B Drug Market Share by Type (2021-2032) Figure 28. North America Hepatitis B Drug Market Share by Application (2021-2032) Figure 29. North America Hepatitis B Drug Market Share by Country (2021-2032) Figure 30. United States Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 31. Canada Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 34. Europe Hepatitis B Drug Market Share by Type (2021-2032) Figure 35. Europe Hepatitis B Drug Market Share by Application (2021-2032) Figure 36. Europe Hepatitis B Drug Market Share by Country (2021-2032) Figure 37. Germany Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 38. France Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 40. Italy Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 41. Russia Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 44. China Hepatitis B Drug Market Share by Type (2021-2032) Figure 45. China Hepatitis B Drug Market Share by Application (2021-2032) Figure 46. Asia Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 47. Asia Hepatitis B Drug Market Share by Type (2021-2032) Figure 48. Asia Hepatitis B Drug Market Share by Application (2021-2032) Figure 49. Asia Hepatitis B Drug Market Share by Country (2021-2032) Figure 50. Japan Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 54. India Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 55. Australia Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Hepatitis B Drug Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Hepatitis B Drug Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Hepatitis B Drug Market Share by Country (2021-2032) Figure 60. Brazil Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 65. UAE Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 67. Chile Hepatitis B Drug Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tenofovir
  • Telbivudine
  • Lamivudine
  • Entecavir
  • Adefovir
  • Others
Applications
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Others
Companies covered
  • Bristol-Myers Squibb
  • Gilead Sciences
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma
  • AbbVie
  • GlaxoSmithKline
  • Roche
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Hepatitis B Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tenofovir
  5. 1.2.3 Telbivudine
  6. 1.2.4 Lamivudine
  7. 1.2.5 Entecavir
  8. 1.2.6 Adefovir
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Hepatitis B Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital Pharmacies
  13. 1.3.3 Retail Pharmacies & Drug Stores
  14. 1.3.4 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Hepatitis B Drug Growth Trends by Region
  17. 1.5.1 Global Hepatitis B Drug Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Hepatitis B Drug Market Size by Region (2021-2026)
  19. 1.5.3 Hepatitis B Drug Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Hepatitis B Drug Market Dynamics
  1. 2.1 Hepatitis B Drug Industry Trends
  2. 2.2 Hepatitis B Drug Industry Drivers
  3. 2.3 Hepatitis B Drug Industry Opportunities and Challenges
  4. 2.4 Hepatitis B Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Hepatitis B Drug Revenue by Company (2021-2026)
  2. 3.2 Global Hepatitis B Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Hepatitis B Drug Key Company Head office and Area Served
  4. 3.4 Global Hepatitis B Drug Company, Product Type & Application
  5. 3.5 Global Hepatitis B Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Hepatitis B Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Hepatitis B Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Hepatitis B Drug Tier 1, Tier 2, and Tier 3
4 Hepatitis B Drug Market by Type
  1. 4.1 Global Hepatitis B Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Hepatitis B Drug Market Size by Type (2021-2032)
  3. 4.3 Global Hepatitis B Drug Market Size Share by Type (2021-2032)
5 Hepatitis B Drug Market by Application
  1. 5.1 Global Hepatitis B Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Hepatitis B Drug Market Size by Application (2021-2032)
  3. 5.3 Global Hepatitis B Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Hepatitis B Drug Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 Gilead Sciences
  8. 6.2.1 Gilead Sciences Company Information
  9. 6.2.2 Gilead Sciences Business Overview
  10. 6.2.3 Gilead Sciences Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Gilead Sciences Hepatitis B Drug Product Portfolio
  12. 6.2.5 Gilead Sciences Recent Developments
  13. 6.3 Merck & Co. Inc.
  14. 6.3.1 Merck & Co. Inc. Company Information
  15. 6.3.2 Merck & Co. Inc. Business Overview
  16. 6.3.3 Merck & Co. Inc. Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck & Co. Inc. Hepatitis B Drug Product Portfolio
  18. 6.3.5 Merck & Co. Inc. Recent Developments
  19. 6.4 Mitsubishi Tanabe Pharma
  20. 6.4.1 Mitsubishi Tanabe Pharma Company Information
  21. 6.4.2 Mitsubishi Tanabe Pharma Business Overview
  22. 6.4.3 Mitsubishi Tanabe Pharma Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mitsubishi Tanabe Pharma Hepatitis B Drug Product Portfolio
  24. 6.4.5 Mitsubishi Tanabe Pharma Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AbbVie Hepatitis B Drug Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GlaxoSmithKline Hepatitis B Drug Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Roche Hepatitis B Drug Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Novartis Hepatitis B Drug Product Portfolio
  48. 6.8.5 Novartis Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Hepatitis B Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Johnson & Johnson Hepatitis B Drug Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
7 North America
  1. 7.1 North America Hepatitis B Drug Market Size (2021-2032)
  2. 7.2 North America Hepatitis B Drug Market Size by Type
  3. 7.2.1 North America Hepatitis B Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Hepatitis B Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Hepatitis B Drug Market Share by Type (2021-2032)
  6. 7.3 North America Hepatitis B Drug Market Size by Application
  7. 7.3.1 North America Hepatitis B Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Hepatitis B Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Hepatitis B Drug Market Share by Application (2021-2032)
  10. 7.4 North America Hepatitis B Drug Market Size by Country
  11. 7.4.1 North America Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Hepatitis B Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Hepatitis B Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Hepatitis B Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Hepatitis B Drug Market Size (2021-2032)
  2. 8.2 Europe Hepatitis B Drug Market Size by Type
  3. 8.2.1 Europe Hepatitis B Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Hepatitis B Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Hepatitis B Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Hepatitis B Drug Market Size by Application
  7. 8.3.1 Europe Hepatitis B Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Hepatitis B Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Hepatitis B Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Hepatitis B Drug Market Size by Country
  11. 8.4.1 Europe Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Hepatitis B Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Hepatitis B Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Hepatitis B Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Hepatitis B Drug Market Size (2021-2032)
  2. 9.2 China Hepatitis B Drug Market Size by Type
  3. 9.2.1 China Hepatitis B Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Hepatitis B Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Hepatitis B Drug Market Share by Type (2021-2032)
  6. 9.3 China Hepatitis B Drug Market Size by Application
  7. 9.3.1 China Hepatitis B Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Hepatitis B Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Hepatitis B Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Hepatitis B Drug Market Size (2021-2032)
  2. 10.2 Asia Hepatitis B Drug Market Size by Type
  3. 10.2.1 Asia Hepatitis B Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Hepatitis B Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Hepatitis B Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Hepatitis B Drug Market Size by Application
  7. 10.3.1 Asia Hepatitis B Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Hepatitis B Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Hepatitis B Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Hepatitis B Drug Market Size by Country
  11. 10.4.1 Asia Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Hepatitis B Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Hepatitis B Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Hepatitis B Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Hepatitis B Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Hepatitis B Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Hepatitis B Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Hepatitis B Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Hepatitis B Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Hepatitis B Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Hepatitis B Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Hepatitis B Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Hepatitis B Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Hepatitis B Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Hepatitis B Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Hepatitis B Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Hepatitis B Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Hepatitis B Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst